u/hassan_nilsen
Contributes reviews on supplier material. Based in Ibadan.
member · joined 14 May 2025
Overview — page 3 of 5
comment on [Discussion] the stopped advice in here is 17 years out of date in c/darkspot · 20 points · 8 months ago
Did anything else change in the same window?
comment on retatrutide vs triple agonist — genuinely asking which matters more in c/retatrutide · 137 points · 8 months ago
This is correct.
Disagree on that part. 95.1% and 96.2% on the same vial is normal.
comment on am I the only one who found triple agonist harder than the injections in c/retatrutide · 111 points · 9 months ago
research use only, handling and analysis, not protocols
comment on someone explain stopped to me like I have not read a paper in years in c/darkspot · -21 points · 9 months ago
failures, regrets, things that went wrong
comment on is it normal to get fatigue at week 90 in c/retatrutide · 17 points · 9 months ago
Strongly agree. Heart rate escalation needs the actual data, not impressions.
comment on [Meta] the crypto rule is doing its job and people should stop complaining in c/cryptopay · 1 points · 9 months ago
Stablecoin or other?
comment on switched from 2.5mg to 2.4mg and the sulphur burps got better, not worse in c/retatrutide · 15 points · 9 months ago
the weight curves are unusually steep, which makes predicting individual response harder
comment on the TRIUMPH thing finally clicked for me and I want to write it down in c/retatrutide · 1 points · 10 months ago
Strongly agree. Heart rate escalation needs the actual data, not impressions.
comment on nobody warned me about sulphur burps and I would have liked the warning in c/tirzepatide · -21 points · 10 months ago
What was the trial arm you are quoting from? SURMOUNT-1, -2, -3 are all different.
comment on does glucagon actually matter or is it forum lore at this point in c/retatrutide · 66 points · 11 months ago
Which trial arm and what was the n?
comment on [Question] how do you actually verify SURPASS in c/tirzepatide · 44 points · 11 months ago
The dual agonism story is real.
Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.
comment on why does nobody talk about SURPASS in c/tirzepatide · 67 points · 11 months ago
Is that on Mounjaro pens or research tirzepatide?
comment on week 11 check-in — 31kg down, muscle cramps manageable, one thing confusing me in c/retatrutide · 166 points · 11 months ago
The heart rate signal in TRIUMPH is real and concerning. Higher doses had higher mean HR changes.
comment on why does nobody talk about VendorInvestigate in c/vendorvetting · 41 points · 11 months ago
The confident tone is doing a lot of work that the evidence is not.
comment on unpopular opinion: 15mg is massively overrated in c/tirzepatide · 275 points · 1 year ago
This matches the trial data. SURMOUNT-1 was 94.2% body weight at 20 weeks.
comment on [Discussion] can we stop arguing about PeptideMeter until somebody posts a number in c/vendorvetting · 156 points · 1 year ago
This is the "correlation is mechanism" thing again. You changed three variables at once.
comment on my ALT moved and I cannot work out whether failure is why in c/darkspot · 5 points · 1 year ago
the 4 order that disappeared from GL Biochem
comment on what went wrong is the most under-discussed thing in c/progresspics in c/darkspot · 48 points · 1 year ago
Disagree but this is the good kind of wrong — it is specific enough to be checked.
comment on am I the only one who found GIP harder than the injections in c/tirzepatide · 371 points · 1 year ago
Removed a chain here.
Adding to this: SURPASS is doing more work than the comment implies.
comment on why does nobody talk about dose escalation in c/retatrutide · 421 points · 1 year ago
Research use material only, no human-use approval anywhere. Posts must describe what happened, not instruct strangers.